What is Anika Therapeutics's change in AR?

Anika Therapeutics (ANIK) reported change in AR of $2.18M in Q1 2026.

How has Anika Therapeutics's change in AR changed year-over-year?

Anika Therapeutics's change in AR increased by 171.9% year-over-year, from -$3.03M to $2.18M.

What does change in AR mean?

Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.

Anika Therapeutics ANIK Change in AR

Change in AR at other companies

StrykerSYK

-$444M-208%

Pacira BioSciences, Inc.PCRX

$1.57M+118%

BioventusBVS

-$7.32M+18.7%

Xtant Medical HoldingsXTNT

-$444K-114%

Globus MedicalGMED

$13.4M+159%

Organogenesis Holdings Inc.ORGO

-$104.5M-1,744%

Other financials

Income statement

See full

Revenue$29.6M+13.2%

Net income-$5.1M-3.8%

Balance sheet

See full

Cash & equivalents$41.0M-23.1%

Total debt$25.7M+1.2%

Total equity$133.9M-9.8%

Total assets$179.4M-5.9%

Cash flow

See full

Operating cash flow-$4.8M-3,628%

CapEx$1.4M-49.3%

Free cash flow-$6.3M-112%

Valuation

See full

Market cap$204.37M+31.6%

Enterprise value$189.09M+48.7%

P/S1.8×+0.1×

Profitability

See full

Net margin-9.8%-4.4pp

FCF margin0.9%—

Returns & leverage

See full

Return on equity-8%-3.4pp

Debt / equity0.2×0.0×

Current ratio4.5×-1.3×

Where this comes from

Reported directly by Anika Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Anika Therapeutics's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Anika Therapeutics's change in AR?: Anika Therapeutics (ANIK) reported change in AR of $2.18M in Q1 2026.
How has Anika Therapeutics's change in AR changed year-over-year?: Anika Therapeutics's change in AR increased by 171.9% year-over-year, from -$3.03M to $2.18M.
What does change in AR mean?: Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.